Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
24.02
-0.13 (-0.54%)
At close: Dec 5, 2025, 4:00 PM EST
24.11
+0.09 (0.37%)
After-hours: Dec 5, 2025, 5:45 PM EST
Progyny Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for Progyny stock ranges from a low of $25 to a high of $30. The average analyst price target of $27.25 forecasts a 13.45% increase in the stock price over the next year.
Price Target: $27.25 (+13.45%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Progyny stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $23 → $26 | Hold | Maintains | $23 → $26 | +8.24% | Nov 17, 2025 |
| Keybanc | Keybanc | Hold → Buy Upgrades $30 | Hold → Buy | Upgrades | $30 | +24.90% | Nov 12, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $25 → $26 | Hold | Maintains | $25 → $26 | +8.24% | Nov 11, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $23 → $25 | Hold | Maintains | $23 → $25 | +4.08% | Aug 26, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $21 → $23 | Hold | Maintains | $21 → $23 | -4.25% | Aug 20, 2025 |
Financial Forecast
Revenue This Year
1.30B
from 1.17B
Increased by 11.55%
Revenue Next Year
1.43B
from 1.30B
Increased by 9.52%
EPS This Year
0.79
from 0.57
Increased by 38.33%
EPS Next Year
1.08
from 0.79
Increased by 36.35%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.4B | 1.6B | ||||
| Avg | 1.3B | 1.4B | ||||
| Low | 1.2B | 1.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 16.6% | 19.3% | ||||
| Avg | 11.5% | 9.5% | ||||
| Low | 6.3% | 3.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.88 | 1.98 | ||||
| Avg | 0.79 | 1.08 | ||||
| Low | 0.63 | 0.74 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 229.7% | 151.7% | ||||
| Avg | 38.3% | 36.4% | ||||
| Low | 10.0% | -5.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.